Data gathered: December 26
AI Stock Analysis - Insulet (PODD)
Analysis generated December 12, 2024. Powered by Chat GPT.
Insulet Corporation is a leading player in the medical device industry, primarily focusing on the development and commercialization of products for people with insulin-dependent diabetes. The company's flagship product, the Omnipod Insulin Management System, helps simplify diabetes management by providing a convenient and effective insulin delivery method.
Stock Alerts - Insulet (PODD)
 |
Insulet | December 20 Price is up by 5.2% in the last 24h. |
|
Insulet | December 18 Insider Alert: Benjamin Eric is selling shares |
|
Insulet | December 12 Insider Alert: Budden Lauren is selling shares |
|
Insulet | November 8 Price is up by 10.8% in the last 24h. |
Alternative Data for Insulet
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 240 | Sign up | Sign up | Sign up |
| Sentiment | 93 | Sign up | Sign up | Sign up |
| Webpage traffic | 76,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | 37 | Sign up | Sign up | Sign up |
| Patents | 272 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 6,900 | Sign up | Sign up | Sign up |
| Facebook Followers | 81,871 | Sign up | Sign up | Sign up |
| Instagram Followers | 55,882 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,776 | Sign up | Sign up | Sign up |
| Twitter Followers | 8,001 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 84 | Sign up | Sign up | Sign up |
| Linkedin Employees | 3,527 | Sign up | Sign up | Sign up |
About Insulet
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
| Price | $263.23 |
| Target Price | Sign up |
| Volume | 139,770 |
| Market Cap | $18.5B |
| Year Range | $161.02 - $275.7 |
| Dividend Yield | 0% |
| PE Ratio | 44.84 |
| Analyst Rating | 88% buy |
| Industry | Medical Devices |
In the news
 |
Insulet (PODD) – Investment Analysts’ Weekly Ratings ChangesDecember 25 - ETF Daily News |
Insulet Corp. stock outperforms competitors despite losses on the dayDecember 24 - MarketWatch |
|
|
Insulet Co. (NASDAQ:PODD) Receives Consensus Rating of “Moderate Buy” from AnalystsDecember 23 - ETF Daily News |
|
Stifel Financial Corp Has $2.45 Million Position in Insulet Co. (NASDAQ:PODD)December 19 - ETF Daily News |
 |
Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its IndustryDecember 19 - Yahoo |
|
Insulet Co. (NASDAQ:PODD) Position Reduced by HighTower Advisors LLCDecember 19 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 544M | 167M | 377M | 78M | 91M | 0.900 |
| Q2 '24 | 489M | 158M | 331M | 189M | 57M | 0.550 |
| Q1 '24 | 442M | 135M | 307M | 52M | 68M | 0.730 |
| Q4 '23 | 510M | 149M | 361M | 103M | 117M | 1.400 |
| Q3 '23 | 433M | 139M | 293M | 52M | 67M | 0.710 |
Insider Transactions View All
| Benjamin Eric filed to sell 18,702 shares at $267.6. December 17 '24 |
| Budden Lauren filed to sell 5,733 shares at $275.6. December 11 '24 |
| Hopfield Jessica filed to sell 26,917 shares at $225.3. September 12 '24 |
| Scannell Timothy J filed to sell 30,586 shares at $225.8. September 11 '24 |
| Budden Lauren filed to sell 6,609 shares at $221.4. September 10 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$91.11 0% | 48 |
 |
Edwards LifesciencesEW |
$75.69 0% | 33 |
 |
Intuitive SurgicalISRG |
$537.36 0% | 76 |
 |
MedtronicMDT |
$81.54 0% | 49 |
 |
StrykerSYK |
$370.78 0% | 50 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Christine Smith Democrat |
Apr 19, 24 | Sell | $50K - $100K |
| Markwayne Mullin Republican |
Jan 26, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Sell | $1K - $15K |
Read more about Insulet (PODD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Insulet?
The Market Cap of Insulet is $18.5B.
What is Insulet's PE Ratio?
As of today, Insulet's PE (Price to Earnings) ratio is 44.84.
What is the current stock price of Insulet?
Currently, the price of one share of Insulet stock is $263.23.
How can I analyze the PODD stock price chart for investment decisions?
The PODD stock price chart above provides a comprehensive visual representation of Insulet's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Insulet shares. Our platform offers an up-to-date PODD stock price chart, along with technical data analysis and alternative data insights.
Does PODD offer dividends to its shareholders?
As of our latest update, Insulet (PODD) does not offer dividends to its shareholders. Investors interested in Insulet should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Insulet?
Some of the similar stocks of Insulet are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.